SEARCH

Current Location: DOTmed News > Industry Headlines > This Story


Log in or Register to rate this News Story
Forward Printable StoryPrint Comment

 

More Industry Headlines

Philips suspends CT and PET/CT production at Ohio facility Setback for customers and the company.

Varian's seven year patent dispute comes to an end Company will pay about $35 million.

FDA OKs GE's new CT scanner Ideal for challenging cases.

MRI technique can help treat concussion patients Measures white brain matter damage.

What's the big-picture impact of HIT on health care? Q&A with thought leader Bipin Thomas.

ABT's compact biomarker generator comes to Russia Ideal for the growing Russian market.

Special report: Contrast media One size does not fit all.

ClearMRI gets FDA clearance for MRI adaptor New option to extend the life of MRI systems.

Sebelius steps down from HHS post Sylvia Mathews Burwell to succeed Sebelius.

Physician payment data now available CMS releases records and AMA pushes back.

FDA deems Boston Scientific imaging catheter recall Class 1

by Brendon Nafziger , DOTmed News Associate Editor
The Food and Drug Administration said Tuesday a recall of more than 110,000 Boston Scientific imaging catheters used with intravascular ultrasound systems was deemed Class 1, its most serious.

The recall, announced last month, applies to the iCross 40 Mhz Coronary Imaging Catheter, sold in the United States and its territories, and the Atlantis SR Pro2 version, distributed internationally, the FDA said. The devices are used to check for pathologies inside the coronary arteries for patients who are candidates for angioplasties.

Story Continues Below Advertisement

Stretcher pads & mattress discounts for DOTmed users, call (800)448-6163

North America Mattress Corp. offers best pricing for replacement pads and mattresses. Buy direct from the manufacture and save.



The FDA said the catheter tip can snap inside the patient, causing tissue and blood vessel injury, or even a heart attack.

The Natick, Mass.-based device company first announced a voluntary recall of the products in a May 27 letter to customers. At the time, the recall was said to affect 29,664 units.

In its notice, Boston Scientific said it had confirmed eight cases of catheter tip detachments in the United States and Puerto Rico due to "embrittlement" between April 1, 2010 and May 10, 2011. Based on market data, this translates to a break rate of 0.027 percent, the company said.

"To date, the majority of confirmed brittle tip detachments have been successfully retrieved (typically snared percutaneously)," the company said in a statement. "Because the potential for tip detachment is undetectable prior to use, modifications to the IVUS procedure will have little impact on the likelihood of occurrence of these events."

Boston Scientific said it would replace affected catheters free of charge.

Class 1 recalls mean there's a reasonable probability that use of the product could result in serious injury or death, the FDA said. Adverse events should be reported to the FDA's Medwatch Program by phone at 1-800-FDA-1088 or on its website, www.fda.gov/medwatch.

Interested in Medical Industry News? Subscribe to DOTmed's weekly news email and always be informed. Click here, it takes just 30 seconds.

You Must Be Logged In To Post A Comment

Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2014 DOTmed.com, Inc.
ALL RIGHTS RESERVED